>
Fa   |   Ar   |   En
   Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells  
   
نویسنده uzu m. ,sato h. ,yamada r. ,kashiba t. ,shibata y. ,yamaura k. ,ueno k.
منبع journal of pharmacological sciences - 2015 - دوره : 128 - شماره : 1 - صفحه:17 -26
چکیده    Connexin (cx) makes up a type of intercellular channel called gap junction (gj). gj plays a regulatory role in cellular physiology. the cx expression level is often decreased in cancer cells compared to that in healthy ones,and the restoration of its expression has been shown to exert antiproliferative effects. this work aims to evaluate the effect of the restoration of connexin 43 (cx43) (the most ubiquitous cx subtype) expression on sunitinib (su)-induced cytotoxicity in malignant mesothelioma (mm) cells. increased cx43 expression in an mm cell line (h28) improved the ability of su to inhibit receptor tyrosine kinase (rtk) signaling. moreover,higher cx43 expression promoted su-induced apoptosis. the cell viability test revealed that cx43 enhanced the cytotoxic effect of su in a gj-independent manner. the effect of cx43 on a proapoptotic factor,bax,was then investigated. the interaction between cx43 and bax was confirmed by immunoprecipitation. furthermore,higher cx43 expression increased the production of a cleaved (active) form of bax during su-induced apoptosis with no alteration in total bax expression. these findings indicate that cx43 most likely increases sensitivity to su in h28 through direct interaction with bax. in conclusion,we found that cx43 overcame the chemoresistance of mm cells. © 2015 the authors. authors. production and hosting by elsevier b.v. on behalf of japanese pharmacological society. this is an open access article under the cc by-nc-nd license.
کلیدواژه Chemotherapy; Connexin; Drug resistance; Mesothelioma; Sunitinib
آدرس department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, department of geriatric pharmacology and therapeutics,graduate school of pharmaceutical sciences,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan, center for preventive medical science,chiba university,chuo-ward,1-8-1 inohana,chiba-city,chiba,260-8675, Japan
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved